Table 2 Clinical characteristics of the patients
Characteristics | Patients n (%) |
|---|---|
Form of TB | Â |
   S+ PTB* | 205 (96.7) |
   S+ PTB* and EPTB†| 7 (3.3) |
Sputum grading | Â |
   High-grade | 131 (61.8) |
   Low-grade | 81 (38.2) |
Lung cavities | Â |
   Yes | 102 (48.1) |
   No | 110 (51.9) |
Persistent cough at the end of the intensive phase | Â |
   Yes | 52 (24.5) |
   No | 160 (75.5) |
Persistent cough at the end of the treatment | Â |
   Yes | 12 (5.7) |
   No | 200 (94.3) |
Co-morbidities ‡ |  |
   Diabetes | 90 (42.5) |
   Hypertension | 31 (14.6) |
   Acquired immunodeficiency syndrome | 9 (4.2) |
   Other | 28 (13.2) |
Twice-weekly dose | Â |
   Yes | 57 (26.9) |
   No | 155 (73.1) |
Prolonged treatment duration (>6Â months) | Â |
   Yes | 157 (74.1) |
   No | 55 (25.9) |